{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:50:54Z","timestamp":1794606654098,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangzhou Science and Technology Planning Project","award":["No. 2024A03J1156"],"award-info":[{"award-number":["No. 2024A03J1156"]}]},{"name":"Zhongshan Social Welfare Science and Technology Research Project","award":["No. 2022B3001"],"award-info":[{"award-number":["No. 2022B3001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02318-5","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:15:31Z","timestamp":1751368531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lycorine hydrochloride inhibits cholangiocarcinoma through cholesterol biosynthesis and PTPN11 nuclear translocation"],"prefix":"10.1186","volume":"23","author":[{"given":"Fengyun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingtian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanni","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fugui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"2318_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin. 2023;73:198\u2013222.","journal-title":"CA Cancer J Clin"},{"key":"2318_CR2","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41571-023-00770-1","volume":"20","author":"SI Ilyas","year":"2023","unstructured":"Ilyas SI, Affo S, Goyal L, Lamarca A, Sapisochin G, Yang JD, et al. Cholangiocarcinoma - novel biological insights and therapeutic strategies. Nat Rev Clin Oncol. 2023;20:470\u201386.","journal-title":"Nat Rev Clin Oncol"},{"key":"2318_CR3","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273\u201381.","journal-title":"N Engl J Med"},{"key":"2318_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","volume":"72","author":"RK Kelley","year":"2020","unstructured":"Kelley RK, Bridgewater J, Gores GJ, Zhu AX. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72:353\u201363.","journal-title":"J Hepatol"},{"key":"2318_CR5","doi-asserted-by":"crossref","unstructured":"Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z. Lipid metabolism and cancer. J Exp Med 218 (2021).","DOI":"10.1084\/jem.20201606"},{"key":"2318_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang B, Song BL, Xu C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat Metab. 2020;2:132\u201341.","journal-title":"Nat Metab"},{"key":"2318_CR7","doi-asserted-by":"publisher","first-page":"188394","DOI":"10.1016\/j.bbcan.2020.188394","volume":"1874","author":"H Xu","year":"2020","unstructured":"Xu H, Zhou S, Tang Q, Xia H, Bi F. Cholesterol metabolism: new functions and therapeutic approaches in cancer. Biochim Biophys Acta Rev Cancer. 2020;1874:188394.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2318_CR8","doi-asserted-by":"crossref","unstructured":"Ha NT, Lee CH. Roles of Farnesyl-Diphosphate farnesyltransferase 1 in tumour and tumour microenvironments. Cells 9 (2020).","DOI":"10.3390\/cells9112352"},{"key":"2318_CR9","doi-asserted-by":"publisher","first-page":"938502","DOI":"10.3389\/fonc.2022.938502","volume":"12","author":"Y Zou","year":"2022","unstructured":"Zou Y, Zhang H, Bi F, Tang Q, Xu H. Targeting the key cholesterol biosynthesis enzyme squalene monooxygenasefor cancer therapy. Front Oncol. 2022;12:938502.","journal-title":"Front Oncol"},{"key":"2318_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbrc.2021.03.049","volume":"552","author":"A Nakae","year":"2021","unstructured":"Nakae A, Kodama M, Okamoto T, Tokunaga M, Shimura H, Hashimoto K, et al. Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1. Biochem Biophys Res Commun. 2021;552:120\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"2318_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1164\/rccm.201404-0714OC","volume":"190","author":"YF Yang","year":"2014","unstructured":"Yang YF, Jan YH, Liu YP, Yang CJ, Su CY, Chang YC, et al. Squalene synthase induces tumor necrosis factor receptor 1 enrichment in lipid rafts to promote lung cancer metastasis. Am J Respir Crit Care Med. 2014;190:675\u201387.","journal-title":"Am J Respir Crit Care Med"},{"key":"2318_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/pcan.2012.14","volume":"15","author":"Y Fukuma","year":"2012","unstructured":"Fukuma Y, Matsui H, Koike H, Sekine Y, Shechter I, Ohtake N, et al. Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer. Prostate Cancer Prostatic Dis. 2012;15:339\u201345.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2318_CR13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/cas.15248","volume":"113","author":"H Jiang","year":"2022","unstructured":"Jiang H, Tang E, Chen Y, Liu H, Zhao Y, Lin M, et al. Squalene synthase predicts poor prognosis in stage I-III colon adenocarcinoma and synergizes squalene epoxidase to promote tumor progression. Cancer Sci. 2022;113:971\u201385.","journal-title":"Cancer Sci"},{"key":"2318_CR14","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41467-020-15795-8","volume":"11","author":"ML Weng","year":"2020","unstructured":"Weng ML, Chen WK, Chen XY, Lu H, Sun ZR, Yu Q, et al. Fasting inhibits aerobic Glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT\/mTOR\/HIF1alpha pathway suppression. Nat Commun. 2020;11:1869.","journal-title":"Nat Commun"},{"key":"2318_CR15","doi-asserted-by":"publisher","first-page":"19435","DOI":"10.1038\/srep19435","volume":"6","author":"DN Brown","year":"2016","unstructured":"Brown DN, Caffa I, Cirmena G, Piras D, Garuti A, Gallo M, et al. Squalene epoxidase is a Bona Fide oncogene by amplification with clinical relevance in breast cancer. Sci Rep. 2016;6:19435.","journal-title":"Sci Rep"},{"key":"2318_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/abbs\/gmw127","volume":"49","author":"Y Qin","year":"2017","unstructured":"Qin Y, Zhang Y, Tang Q, Jin L, Chen Y. SQLE induces epithelial-to-mesenchymal transition by regulating of miR-133b in esophageal squamous cell carcinoma. Acta Biochim Biophys Sin (Shanghai). 2017;49:138\u201348.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2318_CR17","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/bph.16024","volume":"180","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Wu W, Jiao H, Chen Y, Ji X, Cao J, et al. Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF-beta\/SMAD signalling. Br J Pharmacol. 2023;180:1562\u201381.","journal-title":"Br J Pharmacol"},{"key":"2318_CR18","doi-asserted-by":"publisher","first-page":"864244","DOI":"10.3389\/fimmu.2022.864244","volume":"13","author":"W You","year":"2022","unstructured":"You W, Ke J, Chen Y, Cai Z, Huang ZP, Hu P, et al. SQLE, A key enzyme in cholesterol metabolism, correlates with tumor immune infiltration and immunotherapy outcome of pancreatic adenocarcinoma. Front Immunol. 2022;13:864244.","journal-title":"Front Immunol"},{"key":"2318_CR19","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1111\/jcmm.17347","volume":"26","author":"S Wang","year":"2022","unstructured":"Wang S, Dong L, Ma L, Yang S, Zheng Y, Zhang J, et al. SQLE facilitates the pancreatic cancer progression via the lncRNA-TTN-AS1\/miR-133b\/SQLE axis. J Cell Mol Med. 2022;26:3636\u201347.","journal-title":"J Cell Mol Med"},{"key":"2318_CR20","doi-asserted-by":"publisher","first-page":"6613","DOI":"10.1007\/s11033-022-07504-z","volume":"49","author":"F Zhao","year":"2022","unstructured":"Zhao F, Huang Y, Zhang Y, Li X, Chen K, Long Y, et al. SQLE Inhibition suppresses the development of pancreatic ductal adenocarcinoma and enhances its sensitivity to chemotherapeutic agents in vitro. Mol Biol Rep. 2022;49:6613\u201321.","journal-title":"Mol Biol Rep"},{"key":"2318_CR21","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1111\/jog.15576","volume":"49","author":"M Guo","year":"2023","unstructured":"Guo M, Qiao Y, Lu Y, Zhu L, Zheng L. Squalene epoxidase facilitates cervical cancer progression by modulating tumor protein p53 signaling pathway. J Obstet Gynaecol Res. 2023;49:1383\u201392.","journal-title":"J Obstet Gynaecol Res"},{"key":"2318_CR22","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.1038\/s41467-021-25325-9","volume":"12","author":"C Kalogirou","year":"2021","unstructured":"Kalogirou C, Linxweiler J, Schmucker P, Snaebjornsson MT, Schmitz W, Wach S, et al. MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer. Nat Commun. 2021;12:5066.","journal-title":"Nat Commun"},{"key":"2318_CR23","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/cac2.12187","volume":"41","author":"L He","year":"2021","unstructured":"He L, Li H, Pan C, Hua Y, Peng J, Zhou Z, et al. Squalene epoxidase promotes colorectal cancer cell proliferation through accumulating calcitriol and activating CYP24A1-mediated MAPK signaling. Cancer Commun (Lond). 2021;41:726\u201346.","journal-title":"Cancer Commun (Lond)"},{"key":"2318_CR24","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/1759-7714.12944","volume":"10","author":"H Ge","year":"2019","unstructured":"Ge H, Zhao Y, Shi X, Tan Z, Chi X, He M, et al. Squalene epoxidase promotes the proliferation and metastasis of lung squamous cell carcinoma cells though extracellular signal-regulated kinase signaling. Thorac Cancer. 2019;10:428\u201336.","journal-title":"Thorac Cancer"},{"key":"2318_CR25","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1016\/j.ymthe.2022.06.015","volume":"30","author":"LP Hu","year":"2022","unstructured":"Hu LP, Huang W, Wang X, Xu C, Qin WT, Li D, et al. Terbinafine prevents colorectal cancer growth by inducing dNTP starvation and reducing immune suppression. Mol Ther. 2022;30:3284\u201399.","journal-title":"Mol Ther"},{"key":"2318_CR26","doi-asserted-by":"publisher","first-page":"105144","DOI":"10.1016\/j.phrs.2020.105144","volume":"161","author":"L Yi","year":"2020","unstructured":"Yi L, Huang P, Zou X, Guo L, Gu Y, Wen C, et al. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer. Pharmacol Res. 2020;161:105144.","journal-title":"Pharmacol Res"},{"key":"2318_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173:338\u201354. e315.","journal-title":"Cell"},{"key":"2318_CR28","doi-asserted-by":"crossref","unstructured":"Yang L, Liu X, Sui Y, Ma Z, Feng X, Wang F et al. Lycorine Hydrochloride Inhibits the Virulence Traits of Candida albicans. Biomed Res Int 2019, 1851740 (2019).","DOI":"10.1155\/2019\/1851740"},{"key":"2318_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/1743-422X-8-483","volume":"8","author":"J Liu","year":"2011","unstructured":"Liu J, Yang Y, Xu Y, Ma C, Qin C, Zhang L. Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication. Virol J. 2011;8:483.","journal-title":"Virol J"},{"key":"2318_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.intimp.2011.11.018","volume":"12","author":"J Kang","year":"2012","unstructured":"Kang J, Zhang Y, Cao X, Fan J, Li G, Wang Q, et al. Lycorine inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in RAW264.7 cells through suppressing P38 and stats activation and increases the survival rate of mice after LPS challenge. Int Immunopharmacol. 2012;12:249\u201356.","journal-title":"Int Immunopharmacol"},{"key":"2318_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.toxlet.2013.01.018","volume":"218","author":"Z Cao","year":"2013","unstructured":"Cao Z, Yu D, Fu S, Zhang G, Pan Y, Bao M, et al. Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity. Toxicol Lett. 2013;218:174\u201385.","journal-title":"Toxicol Lett"},{"key":"2318_CR32","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.2147\/OTT.S202026","volume":"12","author":"H Hu","year":"2019","unstructured":"Hu H, Wang S, Shi D, Zhong B, Huang X, Shi C, et al. Lycorine exerts antitumor activity against osteosarcoma cells in vitro and in vivo xenograft model through the JAK2\/STAT3 pathway. Onco Targets Ther. 2019;12:5377\u201388.","journal-title":"Onco Targets Ther"},{"key":"2318_CR33","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1158\/1535-7163.MCT-17-0498","volume":"16","author":"H Yu","year":"2017","unstructured":"Yu H, Qiu Y, Pang X, Li J, Wu S, Yin S, et al. Lycorine promotes autophagy and apoptosis via TCRP1\/Akt\/mTOR Axis inactivation in human hepatocellular carcinoma. Mol Cancer Ther. 2017;16:2711\u201323.","journal-title":"Mol Cancer Ther"},{"key":"2318_CR34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jsps.2017.04.036","volume":"25","author":"Y Ji","year":"2017","unstructured":"Ji Y, Yu M, Qi Z, Cui D, Xin G, Wang B, et al. Study on apoptosis effect of human breast cancer cell MCF-7 induced by Lycorine hydrochloride via death receptor pathway. Saudi Pharm J. 2017;25:633\u20137.","journal-title":"Saudi Pharm J"},{"key":"2318_CR35","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1755-148X.2012.01036.x","volume":"25","author":"R Liu","year":"2012","unstructured":"Liu R, Cao Z, Tu J, Pan Y, Shang B, Zhang G, et al. Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry. Pigment Cell Melanoma Res. 2012;25:630\u20138.","journal-title":"Pigment Cell Melanoma Res"},{"key":"2318_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.18632\/aging.102606","volume":"12","author":"M Hu","year":"2020","unstructured":"Hu M, Yu Z, Mei P, Li J, Luo D, Zhang H, et al. Lycorine induces autophagy-associated apoptosis by targeting MEK2 and enhances Vemurafenib activity in colorectal cancer. Aging. 2020;12:138\u201355.","journal-title":"Aging"},{"key":"2318_CR37","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.devcel.2013.08.013","volume":"26","author":"R Tsutsumi","year":"2013","unstructured":"Tsutsumi R, Masoudi M, Takahashi A, Fujii Y, Hayashi T, Kikuchi I, et al. YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function. Dev Cell. 2013;26:658\u201365.","journal-title":"Dev Cell"},{"key":"2318_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cell.2006.01.053","volume":"125","author":"C Mosimann","year":"2006","unstructured":"Mosimann C, Hausmann G, Basler K. Parafibromin\/Hyrax activates wnt\/wg target gene transcription by direct association with beta-catenin\/Armadillo. Cell. 2006;125:327\u201341.","journal-title":"Cell"},{"key":"2318_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15:95\u2013111.","journal-title":"Nat Rev Clin Oncol"},{"key":"2318_CR40","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ejmech.2019.05.027","volume":"176","author":"A Kumar","year":"2019","unstructured":"Kumar A, Jaitak V. Natural products as multidrug resistance modulators in cancer. Eur J Med Chem. 2019;176:268\u201391.","journal-title":"Eur J Med Chem"},{"key":"2318_CR41","doi-asserted-by":"crossref","unstructured":"Ali Abdalla YO, Subramaniam B, Nyamathulla S, Shamsuddin N, Arshad NM, Mun KS et al. Natural Products for Cancer Therapy: A Review of Their Mechanism of Actions and Toxicity in the Past Decade. J Trop Med 2022, 5794350 (2022).","DOI":"10.1155\/2022\/5794350"},{"key":"2318_CR42","doi-asserted-by":"publisher","first-page":"172472","DOI":"10.1016\/j.ejphar.2019.172472","volume":"858","author":"A Mondal","year":"2019","unstructured":"Mondal A, Gandhi A, Fimognari C, Atanasov AG, Bishayee A. Alkaloids for cancer prevention and therapy: current progress and future perspectives. Eur J Pharmacol. 2019;858:172472.","journal-title":"Eur J Pharmacol"},{"key":"2318_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13659-020-00293-7","volume":"11","author":"M Huang","year":"2021","unstructured":"Huang M, Lu JJ, Ding J. Natural products in Cancer therapy: past, present and future. Nat Prod Bioprospect. 2021;11:5\u201313.","journal-title":"Nat Prod Bioprospect"},{"key":"2318_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.canlet.2020.07.010","volume":"493","author":"S Feltrin","year":"2020","unstructured":"Feltrin S, Ravera F, Traversone N, Ferrando L, Bedognetti D, Ballestrero A, et al. Sterol synthesis pathway Inhibition as a target for cancer treatment. Cancer Lett. 2020;493:19\u201330.","journal-title":"Cancer Lett"},{"key":"2318_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10549-014-2996-5","volume":"146","author":"Y Liang","year":"2014","unstructured":"Liang Y, Besch-Williford C, Aebi JD, Mafuvadze B, Cook MT, Zou X, et al. Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071. Breast Cancer Res Treat. 2014;146:51\u201362.","journal-title":"Breast Cancer Res Treat"},{"key":"2318_CR46","doi-asserted-by":"crossref","unstructured":"Wang IH, Huang TT, Chen JL, Chu LW, Ping YH, Hsu KW et al. Mevalonate pathway enzyme HMGCS1 contributes to gastric Cancer progression. Cancers (Basel) 12 (2020).","DOI":"10.3390\/cancers12051088"},{"key":"2318_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2217\/pme-2016-0058","volume":"16","author":"S Tuzmen","year":"2019","unstructured":"Tuzmen S, Hostetter G, Watanabe A, Ekmekci C, Carrigan PE, Shechter I, et al. Characterization of Farnesyl diphosphate Farnesyl transferase 1 (FDFT1) expression in cancer. Per Med. 2019;16:51\u201365.","journal-title":"Per Med"},{"key":"2318_CR48","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1515\/BC.2011.195","volume":"392","author":"A Belter","year":"2011","unstructured":"Belter A, Skupinska M, Giel-Pietraszuk M, Grabarkiewicz T, Rychlewski L, Barciszewski J. Squalene monooxygenase - a target for hypercholesterolemic therapy. Biol Chem. 2011;392:1053\u201375.","journal-title":"Biol Chem"},{"key":"2318_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.apsb.2020.07.010","volume":"11","author":"Z Song","year":"2021","unstructured":"Song Z, Wang M, Ge Y, Chen XP, Xu Z, Sun Y, et al. Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies. Acta Pharm Sin B. 2021;11:13\u201329.","journal-title":"Acta Pharm Sin B"},{"key":"2318_CR50","doi-asserted-by":"publisher","first-page":"11368","DOI":"10.1021\/acs.jmedchem.0c00249","volume":"63","author":"X Yuan","year":"2020","unstructured":"Yuan X, Bu H, Zhou J, Yang CY, Zhang H. Recent advances of SHP2 inhibitors in Cancer therapy: current development and clinical application. J Med Chem. 2020;63:11368\u201396.","journal-title":"J Med Chem"},{"key":"2318_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0065-230X(10)06002-1","volume":"106","author":"KS Grossmann","year":"2010","unstructured":"Grossmann KS, Rosario M, Birchmeier C, Birchmeier W. The tyrosine phosphatase Shp2 in development and cancer. Adv Cancer Res. 2010;106:53\u201389.","journal-title":"Adv Cancer Res"},{"key":"2318_CR52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molcel.2011.05.014","volume":"43","author":"A Takahashi","year":"2011","unstructured":"Takahashi A, Tsutsumi R, Kikuchi I, Obuse C, Saito Y, Seidi A, et al. SHP2 tyrosine phosphatase converts parafibromin\/Cdc73 from a tumor suppressor to an oncogenic driver. Mol Cell. 2011;43:45\u201356.","journal-title":"Mol Cell"},{"key":"2318_CR53","doi-asserted-by":"crossref","unstructured":"Xu X, Hou B, Fulzele A, Masubuchi T, Zhao Y, Wu Z et al. PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2. J Cell Biol 219 (2020).","DOI":"10.1083\/jcb.201905085"},{"key":"2318_CR54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/17512433.2020.1738218","volume":"13","author":"ER Sauter","year":"2020","unstructured":"Sauter ER. Cancer prevention and treatment using combination therapy with natural compounds. Expert Rev Clin Pharmacol. 2020;13:265\u201385.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2318_CR55","doi-asserted-by":"publisher","first-page":"1051998","DOI":"10.3389\/fimmu.2022.1051998","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Li S, Li C, Li T, Huang Y. Remodeling tumor microenvironment with natural products to overcome drug resistance. Front Immunol. 2022;13:1051998.","journal-title":"Front Immunol"},{"key":"2318_CR56","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.phymed.2009.04.001","volume":"16","author":"G Ulrich-Merzenich","year":"2009","unstructured":"Ulrich-Merzenich G, Panek D, Zeitler H, Wagner H, Vetter H. New perspectives for synergy research with the omic-technologies. Phytomedicine. 2009;16:495\u2013508.","journal-title":"Phytomedicine"},{"key":"2318_CR57","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2174\/0929867328666210628131409","volume":"29","author":"M Erkisa","year":"2022","unstructured":"Erkisa M, Sariman M, Geyik OG, Geyik C, Stanojkovic T, Ulukaya E. Natural products as a promising therapeutic strategy to target Cancer stem cells. Curr Med Chem. 2022;29:741\u201383.","journal-title":"Curr Med Chem"},{"key":"2318_CR58","doi-asserted-by":"crossref","unstructured":"Yang C, Mai Z, Liu C, Yin S, Cai Y, Xia C. Natural products in preventing tumor drug resistance and related signaling pathways. Molecules 27 (2022).","DOI":"10.3390\/molecules27113513"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02318-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02318-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02318-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:04:04Z","timestamp":1751371444000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02318-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2318"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02318-5","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol and any procedures involving the care and use of animals in this study were reviewed and approved by the Institutional Animal Care and Use Committee of Zhongshan City People\u2019s Hospital. All the paraffin-embedded tissues of patients used in this study were obtained by informed patient consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"315"}}